New hope for eye cancer patients: targeted liver treatment shows promise
NCT ID NCT04728633
First seen May 08, 2026
Summary
This study tests a procedure called chemoembolization for people with uveal melanoma (an eye cancer) that has spread to the liver. Doctors inject a chemotherapy drug (BCNU) mixed with an oily substance directly into the liver's blood supply, then block the artery with a sponge-like material to trap the drug near the tumors. The goal is to shrink or control the liver tumors. The study involves 28 participants and is in Phase 2.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UVEAL MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Philadelphia, Pennsylvania, 19107, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.